SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes
Serological evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an alternative that allows us to determine the prevalence and dynamics of this infection in populations. The goal of this study was to determine the clinical and sociodemographic dynamics of SARS-CoV-2 infectio...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | Inglés |
| Publicado: |
Oxford University Press
2024
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1093/trstmh/trab094 http://hdl.handle.net/20.500.12324/38929 |
| id |
RepoAGROSAVIA38929 |
|---|---|
| record_format |
dspace |
| institution |
Corporación Colombiana de Investigación Agropecuaria |
| collection |
Repositorio AGROSAVIA |
| language |
Inglés |
| topic |
Investigación agropecuaria - A50 Zona tropical Demografía Coronavirus del síndrome respiratorio agudo grave 2 Salud pública Transversal http://aims.fao.org/aos/agrovoc/c_7979 http://aims.fao.org/aos/agrovoc/c_10328 http://aims.fao.org/aos/agrovoc/c_365a18ab http://aims.fao.org/aos/agrovoc/c_6349 |
| spellingShingle |
Investigación agropecuaria - A50 Zona tropical Demografía Coronavirus del síndrome respiratorio agudo grave 2 Salud pública Transversal http://aims.fao.org/aos/agrovoc/c_7979 http://aims.fao.org/aos/agrovoc/c_10328 http://aims.fao.org/aos/agrovoc/c_365a18ab http://aims.fao.org/aos/agrovoc/c_6349 Garay, Evelin Serrano Coll, Hector Rivero, Ricardo Gastelbondo, Bertha Faccini Martinez, Alvaro Berrocal, Jose Perez, Alejandra Badillo, Maria Martinez Bravo, Caty Botero, Yesica Arrieta, German Calderon, Alfonso Galeano, Ketty Lopez, Yesica Miranda, Jorge Guzman, Camilo Contreras, Veronica Arosemena, Alejandra Contreras, Hector Brango Tarra, Eimi Oviedo Pastrana, Misael Enrique Mattar, Salim SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes |
| description |
Serological evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an alternative that allows us to determine the prevalence and dynamics of this infection in populations. The goal of this study was to determine the clinical and sociodemographic dynamics of SARS-CoV-2 infection in a region of the Colombian Caribbean.Between July and November 2020, a cross-sectional observational study was carried out in Córdoba, located in northeast Colombia in the Caribbean area. Eight municipalities with the largest populations were chosen and 2564 blood samples were taken. A commercial enzyme-linked immunosorbent assay was used with the recombinant protein antigen N of SARS-CoV-2. The people included in the study were asked for sociodemographic and clinical data, which were analysed by statistical methods.A seroprevalence of 40.8% was obtained for SARS-CoV-2 in the Córdoba region. In the bivariate analysis, no differences were observed in seropositivity against SARS-CoV-2 for gender or age range (p>0.05). Higher seropositivity was found in low socio-economic status and symptomatic patients (p<0.0001). A total of 30.7% of the asymptomatic patients were seropositive for SARS-CoV-2, which could be linked to the spread of this infection. In the multivariate analysis, seroconversion was related to poverty and clinical manifestations such as anosmia and ageusia (p<0.05).The high seropositivity in Córdoba is due to widespread SARS-CoV-2 in this population. The relationship between seropositivity and socio-economic status suggests a higher exposure risk to the virus caused by informal economic activities in low-income groups. Clinical manifestations such as anosmia and ageusia could be clinical predictors of infection by the new emergent coronavirus. |
| format |
article |
| author |
Garay, Evelin Serrano Coll, Hector Rivero, Ricardo Gastelbondo, Bertha Faccini Martinez, Alvaro Berrocal, Jose Perez, Alejandra Badillo, Maria Martinez Bravo, Caty Botero, Yesica Arrieta, German Calderon, Alfonso Galeano, Ketty Lopez, Yesica Miranda, Jorge Guzman, Camilo Contreras, Veronica Arosemena, Alejandra Contreras, Hector Brango Tarra, Eimi Oviedo Pastrana, Misael Enrique Mattar, Salim |
| author_facet |
Garay, Evelin Serrano Coll, Hector Rivero, Ricardo Gastelbondo, Bertha Faccini Martinez, Alvaro Berrocal, Jose Perez, Alejandra Badillo, Maria Martinez Bravo, Caty Botero, Yesica Arrieta, German Calderon, Alfonso Galeano, Ketty Lopez, Yesica Miranda, Jorge Guzman, Camilo Contreras, Veronica Arosemena, Alejandra Contreras, Hector Brango Tarra, Eimi Oviedo Pastrana, Misael Enrique Mattar, Salim |
| author_sort |
Garay, Evelin |
| title |
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes |
| title_short |
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes |
| title_full |
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes |
| title_fullStr |
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes |
| title_full_unstemmed |
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes |
| title_sort |
sars-cov-2 in eight municipalities of the colombian tropics: high immunity, clinical and sociodemographic outcomes |
| publisher |
Oxford University Press |
| publishDate |
2024 |
| url |
https://doi.org/10.1093/trstmh/trab094 http://hdl.handle.net/20.500.12324/38929 |
| work_keys_str_mv |
AT garayevelin sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT serranocollhector sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT riveroricardo sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT gastelbondobertha sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT faccinimartinezalvaro sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT berrocaljose sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT perezalejandra sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT badillomaria sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT martinezbravocaty sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT boteroyesica sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT arrietagerman sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT calderonalfonso sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT galeanoketty sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT lopezyesica sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT mirandajorge sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT guzmancamilo sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT contrerasveronica sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT arosemenaalejandra sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT contrerashector sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT brangotarraeimi sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT oviedopastranamisaelenrique sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes AT mattarsalim sarscov2ineightmunicipalitiesofthecolombiantropicshighimmunityclinicalandsociodemographicoutcomes |
| _version_ |
1808105488926113792 |
| spelling |
RepoAGROSAVIA389292024-06-27T20:45:33Z SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes Garay, Evelin Serrano Coll, Hector Rivero, Ricardo Gastelbondo, Bertha Faccini Martinez, Alvaro Berrocal, Jose Perez, Alejandra Badillo, Maria Martinez Bravo, Caty Botero, Yesica Arrieta, German Calderon, Alfonso Galeano, Ketty Lopez, Yesica Miranda, Jorge Guzman, Camilo Contreras, Veronica Arosemena, Alejandra Contreras, Hector Brango Tarra, Eimi Oviedo Pastrana, Misael Enrique Mattar, Salim Investigación agropecuaria - A50 Zona tropical Demografía Coronavirus del síndrome respiratorio agudo grave 2 Salud pública Transversal http://aims.fao.org/aos/agrovoc/c_7979 http://aims.fao.org/aos/agrovoc/c_10328 http://aims.fao.org/aos/agrovoc/c_365a18ab http://aims.fao.org/aos/agrovoc/c_6349 Serological evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an alternative that allows us to determine the prevalence and dynamics of this infection in populations. The goal of this study was to determine the clinical and sociodemographic dynamics of SARS-CoV-2 infection in a region of the Colombian Caribbean.Between July and November 2020, a cross-sectional observational study was carried out in Córdoba, located in northeast Colombia in the Caribbean area. Eight municipalities with the largest populations were chosen and 2564 blood samples were taken. A commercial enzyme-linked immunosorbent assay was used with the recombinant protein antigen N of SARS-CoV-2. The people included in the study were asked for sociodemographic and clinical data, which were analysed by statistical methods.A seroprevalence of 40.8% was obtained for SARS-CoV-2 in the Córdoba region. In the bivariate analysis, no differences were observed in seropositivity against SARS-CoV-2 for gender or age range (p>0.05). Higher seropositivity was found in low socio-economic status and symptomatic patients (p<0.0001). A total of 30.7% of the asymptomatic patients were seropositive for SARS-CoV-2, which could be linked to the spread of this infection. In the multivariate analysis, seroconversion was related to poverty and clinical manifestations such as anosmia and ageusia (p<0.05).The high seropositivity in Córdoba is due to widespread SARS-CoV-2 in this population. The relationship between seropositivity and socio-economic status suggests a higher exposure risk to the virus caused by informal economic activities in low-income groups. Clinical manifestations such as anosmia and ageusia could be clinical predictors of infection by the new emergent coronavirus. 2024-02-22T20:54:57Z 2024-01-22T20:54:57Z 2021 2021 article Artículo científico http://purl.org/coar/resource_type/c_2df8fbb1 info:eu-repo/semantics/article https://purl.org/redcol/resource_type/ART http://purl.org/coar/version/c_970fb48d4fbd8a85 https://doi.org/10.1093/trstmh/trab094 0035-9203 http://hdl.handle.net/20.500.12324/38929 10.1093/trstmh/trab094 reponame:Biblioteca Digital Agropecuaria de Colombia instname:Corporación colombiana de investigación agropecuaria AGROSAVIA eng Transactions of The Royal Society of Tropical Medicine and Hygiene 116 116 139 147 Reina J. El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo. Vacunas. 2020;21(1):17–22. Noor AU, Maqbool F, Bhatti ZA, et al. Epidemiology of CoViD-19 pan demic: recovery and mortality ratio around the globe. Pak J Med Sci. 2020;36(COVID-19-S4):S79–84 Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clini cal therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res. 2020;7(1):1–10. Capobianco G, Saderi L, Aliberti S, et al. COVID-19 in pregnant women: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:543–58. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int/ [accessed 3 March 2021]. Ministerio de Salud y Protección Social. Coronavirus (COVID-19). Reportes y Tableros de Control. Available from: https://www.minsalud. gov.co/salud/publica/PET/Paginas/Covid-19_copia.aspx [accessed 18 May 2021]. Nikolai LA, Meyer CG, Kremsner PG, et al. Asymptomatic SARS coronavirus 2 infection: invisible yet invincible. Int J Infect Dis. 2020;100:112–6. Percivalle E, Cambiè G, Cassaniti I, et al. Prevalence of SARS CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020. Eurosurveillance. 2020;25(24):2001031. Noh JY, Bin SY, Yoon JG, et al. Seroprevalence of anti-SARS-CoV-2 anti bodies among outpatients in southwestern Seoul, Korea. J Korean Med Sci. 2020;35(33):e311. Mattar S, Alvis-Guzman N, Garay E, et al. Severe acute respiratory syndrome coronavirus 2 seroprevalence among adults in a tropi cal city of the Caribbean area, Colombia: are we much closer to herd immunity than developed countries? Open Forum Infect Dis. 2020;7(12):ofaa550. Eurofins. INgezim COVID 19 DR. Available from: https://ingenasa. eurofins-technologies.com/home-es/productos/covid19/ensayo elisa/ingezim-covid-19-dr/ [accessed 16 June 2021]. Franco R, Hopenhayn M, León A. The growing and changing middle class in Latin America: an update. Cepal Rev. 2011 Dodd RY, Xu M, Stramer SL. Change in donor characteristics and anti bodies to SARS-CoV-2 in donated blood in the US, June–August 2020. JAMA. 2020;324(16):1677–9. Reyes-Vega MF, Soto-Cabezas MG, Cárdenas F, et al. SARS-CoV-2 prevalence associated to low socioeconomic status and over crowding in an LMIC megacity: a population-based seroepi demiological survey in Lima, Peru. EClinicalMedicine 2021;34: 100801. Xu X, Sun J, Nie S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med. 2020;26(8): 1193–5. Buss LF, Prete CA, Jr, Abrahim CMM, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371(6526):288–92. Faccini-Martínez ÁA, Rivero R, Garay E, et al. Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia. Int J Infect Dis. 2020;101:191–3. Swedish Public Health Agency. Initial results from ongoing investi gation of antibodies to covid-19 virus. Available from: https://www. folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/ forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-for covid-19-virus/ [accessed 16 June 2021]. Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313–9. Bunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53(3):487–95. Figar S, Pagotto V, Luna L, et al. Community-level SARS-CoV-2 seroprevalence survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research. medRxiv. 2020; doi: 10.1101/2020.07.14.20153858. Mattar S, Martinez-Bravo C, Rivero R, et al. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean. Ann Clin Microbiol Antimicrob. 2020;19(1):58. Bampoe S, Lucas DN, Neall G, et al. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health profes sionals. Anaesthesia. 2020;75(12):1614–9. Paolo C, Carmelo S, Marcello M. Ageusia, gastrointestinal symp toms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy. Int J Infect Dis. 2020;97: 352–3. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to moderate forms of the coronavirus disease (COVID-19): a mul ticenter European study. Eur Arch Otorhinolaryngol. 2020;277(8): 2251–61. European Centre for Disease Prevention and Control. Rapid risk assess ment: risk of COVID-19 transmission related to the end-of-year festive season. Available from: https://www.ecdc.europa.eu/en/publications data/risk-assessment-covid-19-festive-season. [ accessed 16 June 2021]. Attribution-ShareAlike 4.0 International Attribution-ShareAlike 4.0 International http://creativecommons.org/licenses/by-sa/4.0/ application/pdf application/pdf Colombia Oxford University Press Oxford (Inglaterra) Transactions of The Royal Society of Tropical Medicine and Hygiene; Vol. 116, Núm. 116 (2021):Transactions of The Royal Society of Tropical Medicine and Hygiene;p. 139 -147. |